These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 17932473)

  • 41. Biocompatible Peritoneal Dialysis: The Target Is Still Way Off.
    Bartosova M; Schmitt CP
    Front Physiol; 2018; 9():1853. PubMed ID: 30700974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment by functional electrical therapy of an unresolved peritoneal leakage in a peritoneal dialysis patient.
    Sipahi S; Kircelli F; Aydin P; Ulker EA; Sarioglu M; Tamer A
    Perit Dial Int; 2012; 32(2):216-8. PubMed ID: 22383723
    [No Abstract]   [Full Text] [Related]  

  • 43. Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients.
    Stenvinkel P; Chung SH; Heimbürger O; Lindholm B
    Perit Dial Int; 2001; 21 Suppl 3():S157-62. PubMed ID: 11887812
    [No Abstract]   [Full Text] [Related]  

  • 44. Total fluid removal and small solute clearances.
    Nolph K; Khanna R
    Perit Dial Int; 2003; 23(6):608-9; author reply 609-10. PubMed ID: 14703209
    [No Abstract]   [Full Text] [Related]  

  • 45. How significant is the influence of the dialysate on appetite in peritoneal dialysis?
    Wilkie ME; Jenkins SB; Sanders DS
    Perit Dial Int; 2009; 29(6):634-6. PubMed ID: 19910564
    [No Abstract]   [Full Text] [Related]  

  • 46. Glucose degradation products and the peritoneum--how sweet things can turn bitter.
    Yung S; Chan TM
    Perit Dial Int; 2006; 26(3):309-13. PubMed ID: 16722021
    [No Abstract]   [Full Text] [Related]  

  • 47. Should we use biocompatible PD solutions for all patients?
    Fan SL
    Perit Dial Int; 2009; 29(6):630-3. PubMed ID: 19910563
    [No Abstract]   [Full Text] [Related]  

  • 48. The new dialysis fluids--which buffer to choose?
    Liberek T
    Perit Dial Int; 2006; 26(6):645-9. PubMed ID: 17047229
    [No Abstract]   [Full Text] [Related]  

  • 49. Peritoneal dialysis.
    REID R; PENFOLD JB; JONES RN
    Lancet; 1947 Feb; 1(6442):269. PubMed ID: 20284054
    [No Abstract]   [Full Text] [Related]  

  • 50. Peritoneal dialysis.
    ROB CG; RICHARDSON JS
    Lancet; 1947 Feb; 1(6440):195. PubMed ID: 20341549
    [No Abstract]   [Full Text] [Related]  

  • 51. [Kinetics of protein loss in the course of peritoneal dialysis].
    Baran H; Lebek R; Spett K; Twardowski Z
    Pol Arch Med Wewn; 1971 May; 46(5):551-5. PubMed ID: 5566926
    [No Abstract]   [Full Text] [Related]  

  • 52. [Attempt at decreasing protein loss during peritoneal dialysis].
    Polec R
    Pol Arch Med Wewn; 1977 May; 57(5):413-6. PubMed ID: 887457
    [No Abstract]   [Full Text] [Related]  

  • 53. Fluid loss in peritoneal dialysis.
    Buoncristiani U; Timio M
    Ann Intern Med; 1973 Jun; 78(6):981-2. PubMed ID: 4713590
    [No Abstract]   [Full Text] [Related]  

  • 54. Hazard of peritoneal dialysis: contaminated fluid.
    Stewart WK; Anderson DC; Wilson MI
    Br Med J; 1967 Mar; 1(5540):606-7. PubMed ID: 6067166
    [No Abstract]   [Full Text] [Related]  

  • 55. Neuronal damage and shortening of lifespan in
    Schlotterer A; Pfisterer F; Kukudov G; Heckmann B; Henriquez D; Morath C; Krämer BK; Hammes HP; Schwenger V; Morcos M
    Biomed Rep; 2018 Jun; 8(6):540-546. PubMed ID: 29805788
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PD and loss of peritoneal function.
    Jörres A; Witowski J; Bender TO
    Prilozi; 2007 Jul; 28(1):275-81. PubMed ID: 17932473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PD membrane: biological responses to different PD fluids.
    Jörres A; Witowski J
    Contrib Nephrol; 2006; 150():48-53. PubMed ID: 16720991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Membrane longevity in peritoneal dialysis: impact of infection and bio-incompatible solutions.
    Topley N
    Adv Ren Replace Ther; 1998 Jul; 5(3):179-84. PubMed ID: 9686628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glucose degradation products (GDP's) and peritoneal changes in patients on chronic peritoneal dialysis: will new dialysis solutions prevent these changes?
    Krishnan M; Tam P; Wu G; Breborowicz A; Oreopoulos DG
    Int Urol Nephrol; 2005; 37(2):409-18. PubMed ID: 16142577
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypervolemia in peritoneal dialysis patients.
    Lameire N; Van Biesen W
    J Nephrol; 2004; 17 Suppl 8():S58-66. PubMed ID: 15599888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.